-
公开(公告)号:US12091393B2
公开(公告)日:2024-09-17
申请号:US17287914
申请日:2019-10-22
IPC分类号: C07D277/44 , A61K39/39 , A61K39/00
CPC分类号: C07D277/44 , A61K39/39 , A61K2039/55511
摘要: Compounds of formulae (I)-(VD):
A1-Q-L1-A2-L2-Z Formula I
are useful for enhancing or prolonging an immune response, such as, in a vaccine as an adjuvant or a co-adjuvant.-
公开(公告)号:US20180110784A1
公开(公告)日:2018-04-26
申请号:US15565097
申请日:2016-04-07
发明人: Dennis A. Carson , Tomoko Hayashi , Ekihiro Seki
CPC分类号: A61K31/52 , A61K9/0019 , A61K9/0043 , A61K9/0053 , A61K31/519 , A61K47/60 , A61P1/16 , C07D473/02 , C07D487/04 , A61K2300/00
摘要: Methods of using TLR7 conjugates or TLR4 ligands, or a combination thereof, to treat fibrosis are provided.
-
公开(公告)号:US20150366962A1
公开(公告)日:2015-12-24
申请号:US14745394
申请日:2015-06-20
发明人: Dennis A. Carson , Howard B. Cottam , Tomoko Hayashi , Maripat Corr , Peter Palese , Peter Goff
IPC分类号: A61K39/39 , C12N7/00 , A61K39/145
CPC分类号: A61K39/39 , A61K39/12 , A61K2039/545 , A61K2039/55511 , A61K2039/55566 , B82Y5/00 , C12N2760/16034 , C12N2760/16134 , C12N2760/16234 , Y02A50/394 , Y02A50/403 , Y02A50/469 , Y02A50/489
摘要: This disclosure relates to compositions and methods useful to augment an immune response and methods and compositions for inducing immunogenicity to influenza antigens.
摘要翻译: 本公开涉及用于增加免疫应答的组合物和方法以及用于诱导针对流感抗原的免疫原性的方法和组合物。
-
公开(公告)号:US20210380546A1
公开(公告)日:2021-12-09
申请号:US17287914
申请日:2019-10-22
IPC分类号: C07D277/44 , A61K39/39
摘要: Compounds useful as an adjuvant, e.g., formulas (I)-(VI) and uses thereof, for example, with immunogenic moieties or other adjuvants, are provided.
-
公开(公告)号:US20150197527A1
公开(公告)日:2015-07-16
申请号:US14671820
申请日:2015-03-27
IPC分类号: C07D487/04 , A61K31/688 , A61K31/519 , A61K39/00 , A61K39/39
CPC分类号: C07D487/04 , A61K31/519 , A61K31/688 , A61K39/0005 , A61K39/39 , A61K2039/55511 , C07D519/00 , Y02A50/387 , Y02A50/473
摘要: Provided herein, inter alia, are methods and compositions for modulating TLR-4.
摘要翻译: 本文提供了尤其是用于调节TLR-4的方法和组合物。
-
公开(公告)号:US20230365570A1
公开(公告)日:2023-11-16
申请号:US18029899
申请日:2021-10-05
发明人: Dennis A. Carson , Tomoko Hayashi , Mary Patricia Corr , Howard B. cottam , Tadashi Hosoya , Nikunj Shukla
IPC分类号: C07D487/04 , A61P37/06 , C07D307/72
CPC分类号: C07D487/04 , A61P37/06 , C07D307/72
摘要: The disclosure relates to 1H-pyrazolo[3,4-d]pyrimidin-4-amine compounds and 1-nitro-5-amido-disubstituted furan compounds, or a pharmaceutically acceptable salt thereof, and methods for their use in treating, among other conditions, inflammatory diseases or an autoimmune diseases.
-
公开(公告)号:US20220305121A1
公开(公告)日:2022-09-29
申请号:US17635983
申请日:2020-08-15
发明人: Dennis A. Carson , Tomoko Hayashi , Maripat Corr , Howard B. Cottam , Nijunj Shukla , Michael Chan
摘要: Bis-aryl sulfonamide compounds and methods of using those compounds, e.g., in a method of enhancing or prolonging an immune response, are provided. For example, the compounds may be employed with a vaccine and optionally at least one other adjuvant and/or one or more TLR ligands, at least one MAP kinase inhibitor, or any combination thereof.
-
公开(公告)号:US09505768B2
公开(公告)日:2016-11-29
申请号:US14671820
申请日:2015-03-27
IPC分类号: C07D487/04 , A61K31/519 , A61P19/02 , C07D519/00 , A61K31/688 , A61K39/00 , A61K39/39
CPC分类号: C07D487/04 , A61K31/519 , A61K31/688 , A61K39/0005 , A61K39/39 , A61K2039/55511 , C07D519/00 , Y02A50/387 , Y02A50/473
摘要: Provided herein, inter alia, are methods and compositions for modulating TLR-4.
摘要翻译: 本文提供了尤其是用于调节TLR-4的方法和组合物。
-
公开(公告)号:US20150132342A1
公开(公告)日:2015-05-14
申请号:US14536146
申请日:2014-11-07
IPC分类号: C07D239/94 , A61K39/39
CPC分类号: C07D239/94 , A61K39/39 , A61K2039/55511
摘要: Provided herein are compounds and methods for modulating an immune response in a subject in need thereof. Further provided herein are compounds and methods for modulating a toll-like receptor protein.
摘要翻译: 本文提供了用于在有需要的受试者中调节免疫应答的化合物和方法。 本文进一步提供了用于调节长颈状受体蛋白质的化合物和方法。
-
公开(公告)号:US20220152188A1
公开(公告)日:2022-05-19
申请号:US17438934
申请日:2020-03-13
摘要: A method to enhance an immune response in a mammal, and a composition comprising liposomes, a TLR4 agonist and a TLR7 agonist, are provided.
-
-
-
-
-
-
-
-
-